Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression

Background Cervical cancer is a major cause of morbidity and mortality in women worldwide. The underlying mechanisms of its progression are not well understood. In this study, we investigated the role of lymphoid-specific helicase (HELLS) in cervical cancer. Methods We measured HELLS expression in c...

Full description

Bibliographic Details
Main Authors: Weiwei Tie, Fenfen Ge
Format: Article
Language:English
Published: PeerJ Inc. 2023-11-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/16451.pdf
_version_ 1827629698653356032
author Weiwei Tie
Fenfen Ge
author_facet Weiwei Tie
Fenfen Ge
author_sort Weiwei Tie
collection DOAJ
description Background Cervical cancer is a major cause of morbidity and mortality in women worldwide. The underlying mechanisms of its progression are not well understood. In this study, we investigated the role of lymphoid-specific helicase (HELLS) in cervical cancer. Methods We measured HELLS expression in cervical cancer and assessed its function using gain- and loss-of-function experiments. Cell viability was measured using the Cell Counting Kit-8 (CCK8 ) assay, and cell proliferation was analyzed using colony formation and EdU assays. Results We found that HELLS was significantly increased in cervical cancer and that its overexpression promoted cell viability (P < 0.01) and colony formation (P < 0.001). In contrast, si-HELLS suppressed these effects. Moreover, HELLS overexpression inhibited cell death induced by the ferroptosis inducer erastin (P < 0.01). Mechanistically, we found that HELLS promoted cervical cancer proliferation by regulating nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated ferroptosis. Conclusion Our data suggest that HELLS promotes cervical cancer proliferation by inhibiting Nrf2 expression. Therefore, HELLS knockdown may be an effective treatment for cervical cancer.
first_indexed 2024-03-09T13:56:07Z
format Article
id doaj.art-6b99897d83684569a3d28c24e9015369
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T13:56:07Z
publishDate 2023-11-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-6b99897d83684569a3d28c24e90153692023-11-30T15:05:12ZengPeerJ Inc.PeerJ2167-83592023-11-0111e1645110.7717/peerj.16451Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expressionWeiwei Tie0Fenfen Ge1Department of Gynecology, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, ChinaDepartment of Gynecology, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, ChinaBackground Cervical cancer is a major cause of morbidity and mortality in women worldwide. The underlying mechanisms of its progression are not well understood. In this study, we investigated the role of lymphoid-specific helicase (HELLS) in cervical cancer. Methods We measured HELLS expression in cervical cancer and assessed its function using gain- and loss-of-function experiments. Cell viability was measured using the Cell Counting Kit-8 (CCK8 ) assay, and cell proliferation was analyzed using colony formation and EdU assays. Results We found that HELLS was significantly increased in cervical cancer and that its overexpression promoted cell viability (P < 0.01) and colony formation (P < 0.001). In contrast, si-HELLS suppressed these effects. Moreover, HELLS overexpression inhibited cell death induced by the ferroptosis inducer erastin (P < 0.01). Mechanistically, we found that HELLS promoted cervical cancer proliferation by regulating nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated ferroptosis. Conclusion Our data suggest that HELLS promotes cervical cancer proliferation by inhibiting Nrf2 expression. Therefore, HELLS knockdown may be an effective treatment for cervical cancer.https://peerj.com/articles/16451.pdfCervical cancerFerroptosisLymphoid-specific helicaseNuclear factor erythroid 2-related factor 2
spellingShingle Weiwei Tie
Fenfen Ge
Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression
PeerJ
Cervical cancer
Ferroptosis
Lymphoid-specific helicase
Nuclear factor erythroid 2-related factor 2
title Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression
title_full Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression
title_fullStr Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression
title_full_unstemmed Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression
title_short Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression
title_sort lymphoid specific helicase inhibits cervical cancer cells ferroptosis by promoting nrf2 expression
topic Cervical cancer
Ferroptosis
Lymphoid-specific helicase
Nuclear factor erythroid 2-related factor 2
url https://peerj.com/articles/16451.pdf
work_keys_str_mv AT weiweitie lymphoidspecifichelicaseinhibitscervicalcancercellsferroptosisbypromotingnrf2expression
AT fenfenge lymphoidspecifichelicaseinhibitscervicalcancercellsferroptosisbypromotingnrf2expression